5-butyl-9-(1-(2,6-dimethylbenzoyl)piperidin-4-yl)-3-((tetrahydro-2H-pyran-4-yl)methyl)-1-oxa-3,9-diazaspiro[5.5]undecan-2-one

ID: ALA1078014

PubChem CID: 11215950

Max Phase: Preclinical

Molecular Formula: C32H49N3O4

Molecular Weight: 539.76

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCC1CN(CC2CCOCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2

Standard InChI:  InChI=1S/C32H49N3O4/c1-4-5-9-27-23-35(22-26-12-20-38-21-13-26)31(37)39-32(27)14-18-33(19-15-32)28-10-16-34(17-11-28)30(36)29-24(2)7-6-8-25(29)3/h6-8,26-28H,4-5,9-23H2,1-3H3

Standard InChI Key:  BBKNZDXWDHCIOQ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 39 43  0  0  0  0  0  0  0  0999 V2000
    1.4000  -25.8458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8083  -26.5583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6250  -26.5609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0395  -25.8527    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6312  -25.1402    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8083  -25.1359    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.1472  -26.5233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9720  -26.5432    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0064  -25.1180    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1816  -25.0981    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2503  -25.8030    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0729  -25.7817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4678  -25.0562    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2889  -25.0356    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7214  -25.7386    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3265  -26.4640    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4992  -26.4865    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5461  -25.7167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9774  -26.4200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9395  -24.9915    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8028  -26.3949    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2340  -27.0973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8406  -27.8235    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0116  -27.8428    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5841  -27.1397    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7593  -27.1587    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1947  -25.6689    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3936  -27.2715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8038  -27.9873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3890  -28.7004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7992  -29.4162    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0467  -24.4275    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.8645  -25.8565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2803  -25.1439    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1037  -25.1509    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5194  -24.4424    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1137  -23.7237    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.2878  -23.7179    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8675  -24.4309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  3  4  1  0
 18 19  1  0
  7 11  1  0
 18 20  2  0
  8  1  1  0
 19 21  2  0
  1  9  1  0
 21 22  1  0
  9 10  1  0
 22 23  2  0
 10 11  1  0
 23 24  1  0
 12 13  1  0
 24 25  2  0
 25 19  1  0
  4  5  1  0
 25 26  1  0
  5  6  1  0
 21 27  1  0
  7  8  1  0
  2 28  1  0
 28 29  1  0
  1  2  1  0
 29 30  1  0
  1  6  1  0
 30 31  1  0
 12 17  1  0
  5 32  2  0
 13 14  1  0
  4 33  1  0
 14 15  1  0
 33 34  1  0
 34 35  1  0
 15 16  1  0
 16 17  1  0
 11 12  1  0
  2  3  1  0
 15 18  1  0
 34 39  1  0
 35 36  1  0
 36 37  1  0
 37 38  1  0
 38 39  1  0
M  END

Associated Targets(Human)

CCR5 Tclin C-C chemokine receptor type 5 (5640 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver microsomes (16955 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Human immunodeficiency virus 1 (70413 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 539.76Molecular Weight (Monoisotopic): 539.3723AlogP: 5.43#Rotatable Bonds: 7
Polar Surface Area: 62.32Molecular Species: BASEHBA: 5HBD:
#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): #RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 8.99CX LogP: 4.24CX LogD: 2.65
Aromatic Rings: 1Heavy Atoms: 39QED Weighted: 0.46Np Likeness Score: -0.36

References

1. Rotstein DM, Gabriel SD, Makra F, Filonova L, Gleason S, Brotherton-Pleiss C, Setti LQ, Trejo-Martin A, Lee EK, Sankuratri S, Ji C, Derosier A, Dioszegi M, Heilek G, Jekle A, Berry P, Weller P, Mau CI..  (2009)  Spiropiperidine CCR5 antagonists.,  19  (18): [PMID:19674898] [10.1016/j.bmcl.2009.07.122]

Source